Daniel Khalaf
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Papers in
-
- Prostate Cancer Treatment and Research 27
- Sarcoma Diagnosis and Treatment 3
- Renal cell carcinoma treatment 3
-
- Cancer Genomics and Diagnostics 9
- Co-authors
- Kim N. (32 shared papers)Martin Gleave (18 shared papers)Matti Annala (17 shared papers)Alexander W. Wyatt (21 shared papers)Daygen L. Finch (17 shared papers)Joanna Vergidis (17 shared papers)Gillian Vandekerkhove (14 shared papers)Kevin Beja (10 shared papers)
- Journals
- Journal of Clinical Oncology (21 papers)Clinical Cancer Research (3 papers)European Urology (3 papers)Annals of Oncology (2 papers)The Prostate (1 paper)
- Partner nations
- CanadaFinlandUnited Kingdom
In The Last Decade
Daniel Khalaf
40 papers receiving 1.3k citations
Daniel Khalaf's Hit Papers
Peers
Comparison fields: 5 of 49
- Pulmonary and Respiratory Medicine 982
- Cancer Research 418
- Oncology 273
- Radiology, Nuclear Medicine and Imaging 90
- Molecular Biology 242
Countries citing papers authored by Daniel Khalaf
This map shows the geographic impact of Daniel Khalaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Khalaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Khalaf more than expected).
Fields of papers citing papers by Daniel Khalaf
This network shows the impact of papers produced by Daniel Khalaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Khalaf. The network helps show where Daniel Khalaf may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Khalaf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer Hit paper breakdown → | 2018 | 353 |
| 2 | Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial Hit paper breakdown → | 2019 | 218 |
| 3 | 2017 | 170 | |
| 4 | 2019 | 136 | |
| 5 | 2019 | 87 | |
| 6 | 2018 | 59 | |
| 7 | 2021 | 56 | |
| 8 | 2021 | 53 | |
| 9 | 2017 | 31 | |
| 10 | 2014 | 26 | |
| 11 | 2018 | 20 | |
| 12 | 2018 | 17 | |
| 13 | 2018 | 16 | |
| 14 | 2021 | 11 | |
| 15 | 2017 | 10 | |
| 16 | 2017 | 9 | |
| 17 | 2021 | 9 | |
| 18 | 2014 | 8 | |
| 19 | 2018 | 8 | |
| 20 | 2018 | 6 |
About Daniel Khalaf
Daniel Khalaf is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (4 papers), Testicular diseases and treatments (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (982 citations), Cancer Research (418 citations), Oncology (273 citations), Radiology, Nuclear Medicine and Imaging (90 citations) and Molecular Biology (242 citations). Daniel Khalaf has collaborated with scholars based in Canada, Finland and United Kingdom. Frequent co-authors include Kim N., Martin Gleave, Matti Annala, Alexander W. Wyatt, Daygen L. Finch, Joanna Vergidis, Gillian Vandekerkhove, Kevin Beja, Muhammad Zulfiqar and Bernhard J. Eigl. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, European Urology, Annals of Oncology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.